A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS

International Journal of Clinical Practice

Volumn 62, Issue 12, 2008, Pages 1858-1863

  Simon, B ^b   Treat, V ^c   Marco, C ^d   Rosenberg, D ^e   Joseph, J ^d   Hipszer, B ^d   Li, Y ^d   Chervoneva, I ^d   Padron Massara, L ^d   Jabbour, S ^a,d  

^a Drexel University College of Medicine ^*  (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c Main Line Health Heart Center   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e ABINGTON MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN GLARGINE; INSULIN LISPRO;

ADULT; ARTICLE; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; DISEASE SEVERITY; EVALUATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MONITORING; PRIORITY JOURNAL;

ADMINISTRATION, CUTANEOUS; ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INSULIN; MIDDLE AGED;

EID: 55949126350     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2008.01932.x     Document Type: Article

References (10)

1. The Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993 329 : 977 86.
2. DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with longstanding poor glycemic control. Diabetes Care 2002 25 : 2074 80.
3. Hirsch EB, Bode BW, Garg S et al. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care 2005 28 : 533 8.
4. Hanaire-Broutin H, Melki V, Bessieres-Lacombe S, Tauber JP. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. Diabetes Care 2000 23 : 1232 5.
5. Doyle EA, Weinzimer SA, Steffen AT, Ahern JH, Vencent M, Tamborlane WV. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004 27 : 1554 8.
6. Cox D, Gonder-Frederick L, McCall A, Kovatchev B, Clarke W. The effects of glucose fluctuation on cognitive function and QOL: the functional costs of hypoglycaemia and hyperglycaemia among adults with type 1 or type 2 diabetes. Int J Clin Pract 2002 12 (Suppl. 129 20 6.
7. Gross TM, Bode BW, Einhorn D et al. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther 2000 2 : 49 56.
8. Gibbons JD. Nonparametric Statistical Inference, 2nd edn. New York : Marcel Dekker, 1985, Chapter 8.
9. Retnakaran R, Hochman J, DeVries JH et al. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c. Diabetes Care 2004 27 : 2590 6.
10. Tsui E, Barnie A, Ross S, Parkes R, Zinman B. Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection. Diabetes Care 2001 24 : 1722 7.